Health ❯ Healthcare ❯ Medical Research

Drug Development

AI in Medicine Eculizumab Trials Organoids AstraZeneca Eli Lilly Artificial Intelligence in Medicine Anti-inflammatory Treatments Antiviral Therapies Clinical Trials Nonfactor Therapies

3 ARTICLES

2d ago

AI Pipeline Finds Two Novel Antibiotic Leads Against Drug‑Resistant Gonorrhea

A graph neural network that screened millions of virtual compounds produced two preclinical hits, offering a faster route to new drug candidates while those leads still require optimization and human testing.

4 ARTICLES

last wk.

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

9 ARTICLES

9mo ago

Leqembi Launches in Germany for Early Alzheimer’s Patients

3 ARTICLES

10mo ago

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

9 ARTICLES

10mo ago

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

3 ARTICLES

10mo ago

Six-Month Eculizumab Withdrawal Safe for Most aHUS Patients, Study Finds

8 ARTICLES

10mo ago

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

8 ARTICLES

last yr.

NHS England to Introduce Europe’s First Injectable Cancer Immunotherapy

5 ARTICLES

last yr.

DeepMind CEO Proposes AI Could Cure All Diseases Within a Decade

3 ARTICLES

last yr.

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

4 ARTICLES

last yr.

AI Tool Identifies Drug Candidates for Over 17,000 Rare Diseases

7 ARTICLES

last yr.

Pioneers of Obesity Drugs Win Prestigious Lasker Award

Drug Development

AI Pipeline Finds Two Novel Antibiotic Leads Against Drug‑Resistant Gonorrhea

FDA Expands Hympavzi Approval to Patients Aged 6 and Older With Hemophilia

DeepMind and Edison Publish AI ‘Scientist’ Systems as Edison Seals Incyte Deal

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

FDA Approves Koselugo for Adults With NF1-Related Plexiform Neurofibromas

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

Leqembi Launches in Germany for Early Alzheimer’s Patients

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Six-Month Eculizumab Withdrawal Safe for Most aHUS Patients, Study Finds

Never miss stories about

Drug Development

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

NHS England to Introduce Europe’s First Injectable Cancer Immunotherapy

DeepMind CEO Proposes AI Could Cure All Diseases Within a Decade

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

AI Tool Identifies Drug Candidates for Over 17,000 Rare Diseases

Pioneers of Obesity Drugs Win Prestigious Lasker Award

Never miss stories about

Drug Development